Van Hulzen Asset Management, LLC Haemonetics Corp Transaction History
Van Hulzen Asset Management, LLC
- $1.32 Billion
- Q4 2024
A detailed history of Van Hulzen Asset Management, LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Van Hulzen Asset Management, LLC holds 186 shares of HAE stock, worth $11,626. This represents 0.0% of its overall portfolio holdings.
Number of Shares
186
Previous 13,890
98.66%
Holding current value
$11,626
Previous $1.12 Million
98.75%
% of portfolio
0.0%
Previous 0.08%
Shares
2 transactions
Others Institutions Holding HAE
# of Institutions
343Shares Held
52.6MCall Options Held
600KPut Options Held
474K-
Black Rock Inc. New York, NY5.96MShares$373 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.18MShares$324 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.42MShares$276 Million0.29% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.24MShares$265 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.55MShares$160 Million0.12% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.21B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...